Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Mid-range Performer
935.4000 2.85 (0.31%)
NSE Dec 03, 2025 15:31 PM
Volume: 2.0M
 

logo
Natco Pharma Ltd.
25 May 2015
935.40
0.31%
Karvy
Natco Pharma Ltd reported Rs. 2,008 Mn in Net Revenues for Q4 FY15, up by 9.2% YoY, and up by 2.7% on a QoQ basis. Net Revenues increased on the back of higher sales of Formulations which rose by 9.3% YoY and 22.7% QoQ. Also, Bulk Chemicals contributed significantly to the top line, sales of Bulk Chemicals rose by 65.1% YoY and 13.1% on a QoQ basis.
Natco Pharma Ltd. has an average target of 845.00 from 2 brokers.
More from Natco Pharma Ltd.
Recommended